New vaccine uses your own cancer cells to fight recurrence
NCT ID NCT02448173
First seen Jan 05, 2026 · Last updated May 17, 2026 · Updated 28 times
Summary
This study tests a personalized immunotherapy called OncoVax for people with stage II colon cancer. After surgery to remove the tumor, patients receive a vaccine made from their own cancer cells to train the immune system to prevent the cancer from coming back. The trial involves 550 participants and aims to see if the vaccine improves disease-free survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE II COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Halifax Health Medical Center
Port Orange, Florida, 32127, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.